Araris Biotech and Chugai Pharmaceutical Partner to Advance Next-Generation Cancer Therapies
By Daniella Parra Araris Biotech AG, a Swiss oncology biotech firm, has partnered with Chugai...
MOBILion Marks 100 Peer-Reviewed Publications on SLIM Technology
By Daniella Parra MOBILion Systems, Inc. said its SLIM (Structures for Lossless Ion Manipulation) platform,...
Oculis Trial Shows Potential for Optical Neuroprotective Therapy
By Karen Roman Oculis Holding AG (Nasdaq: OCS) said Phase 2 of its neuroprotective candidate...
March Bio Appoints Peter Olagunju as Chair of Board of Directors
By Karen Roman March Biosciences said it elected Peter Olagunju as chair of its Board...
MOBILion Systems Partners with Dr. Oliver Schmitz to Advance Multiomics Research
By Daniella Parra MOBILion Systems said it partnered with Dr. Oliver Schmitz of the University...
Agendia To Unveil Enhanced Breast Cancer Therapy at San Antonio
By Karen Roman Agendia, Inc. said it will present data to assess treatment decisions on patients...
Agendia Presents Chemo Prediction Benefits at Symposium
By Karen Roman Agendia, Inc. said it will present MammaPrint’s ability to predict chemotherapy benefit...
Candel Therapeutics Prostate Cancer Therapy Shows Promise
By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer...
Lisata Therapeutics Completes Enrollment for Cancer Therapy Trial
By Karen Roman Biopharma company Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it finished patient enrollment...
ReAlta Presenting New Results in aGVHD at American Society of Hematology 2024
By Karen Roman ReAlta Life Sciences said it is presenting new data at the American...
© Copyright 2023, ExecEdge